SPEKE HC - DR SINGH & DR BICHA — All Prescriptions & Medications — Page 2
Practice Code: N82650 | LIVERPOOL, L24 2SF
Showing results 51-100 of 458
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Indapamide | 436 | 12.8K | £932 | -49.4% ▼ |
| Esomeprazole | 430 | 16.4K | £1.1K | +6.3% ▲ |
| Gliclazide | 419 | 24.1K | £1.3K | -50.8% ▼ |
| 417 | 51.9K | £2.4K | -12.1% ▼ | |
| Fexofenadine hydrochloride | 411 | 15.5K | £667 | -51.7% ▼ |
| Tamsulosin hydrochloride | 410 | 12.5K | £560 | -69.7% ▼ |
| Thiamine hydrochloride | 409 | 25.3K | £669 | -22.4% ▼ |
| Solifenacin | 402 | 12.6K | £479 | -15.7% ▼ |
| Edoxaban | 385 | 10.8K | £17.9K | -45.0% ▼ |
| Morphine sulfate | 384 | 36.2K | £1.3K | -41.4% ▼ |
| 383 | 745 | £26.2K | -29.7% ▼ | |
| 382 | 382 | £16.8K | +23.0% ▲ | |
| Tiotropium bromide | 380 | 5,605 | £9.1K | +25.0% ▲ |
| Candesartan cilexetil | 375 | 10.7K | £527 | -68.4% ▼ |
| Lactulose | 373 | 194.1K | £1.8K | +13.3% ▲ |
| Zopiclone | 352 | 4,358 | £202 | -36.4% ▼ |
| Nebivolol | 347 | 11.8K | £1.8K | +227.4% ▲ |
| Olanzapine | 340 | 8,398 | £868 | -8.2% ▼ |
| Diazepam | 336 | 6,963 | £164 | -32.5% ▼ |
| Alendronic acid | 331 | 1,540 | £351 | -55.9% ▼ |
| Doxycycline hyclate | 330 | 3,644 | £348 | -35.6% ▼ |
| Linagliptin | 330 | 9,268 | £10.5K | -19.4% ▼ |
| Insulin aspart | 324 | 1,717 | £11.7K | -14.9% ▼ |
| Perindopril erbumine | 322 | 10.7K | £857 | -39.3% ▼ |
| Cetirizine hydrochloride | 313 | 15.1K | £665 | -37.4% ▼ |
| Desogestrel | 309 | 33.8K | £1.0K | -22.0% ▼ |
| Montelukast | 308 | 8,988 | £420 | -55.0% ▼ |
| Lamotrigine | 308 | 24.7K | £4.8K | -47.8% ▼ |
| Rosuvastatin calcium | 307 | 9,786 | £429 | -65.8% ▼ |
| Insulin glargine | 304 | 1,233 | £11.4K | +7.1% ▲ |
| Glyceryl trinitrate | 298 | 397 | £671 | +26.0% ▲ |
| Trazodone hydrochloride | 298 | 8,898 | £411 | +45.8% ▲ |
| Naproxen | 298 | 13.4K | £1.4K | -69.8% ▼ |
| Carbocisteine | 288 | 56.0K | £1.5K | -46.1% ▼ |
| Codeine phosphate | 277 | 21.7K | £744 | -61.4% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 257 | 1.9M | £12.7K | +80.8% ▲ |
| Nicorandil | 254 | 13.0K | £2.0K | +76.4% ▲ |
| 253 | 3,320 | £2.1K | -61.9% ▼ | |
| Dihydrocodeine tartrate | 250 | 15.6K | £1.1K | +28.0% ▲ |
| Mebeverine hydrochloride | 247 | 18.5K | £1.4K | -20.5% ▼ |
| Tirzepatide | 235 | 236 | £22.2K | +21.0% ▲ |
| Hydrocortisone | 234 | 8,395 | £2.1K | -47.8% ▼ |
| Hyoscine butylbromide | 233 | 21.7K | £1.5K | +0.0% vs avg |
| Famotidine | 228 | 10.8K | £6.2K | -53.3% ▼ |
| Mirabegron | 227 | 6,708 | £6.2K | -43.5% ▼ |
| Bendroflumethiazide | 226 | 6,405 | £107 | -70.8% ▼ |
| Buprenorphine | 225 | 1,098 | £4.9K | -38.6% ▼ |
| Sitagliptin | 225 | 6,580 | £484 | -42.3% ▼ |
| Ferrous fumarate | 220 | 20.7K | £750 | -69.6% ▼ |
| 220 | 2,078 | £868 | -11.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.